A validated 0–5 grading scale for assessing peripheral intravenous catheter sites — linking observable signs to clear clinical actions at every stage of phlebitis.
The Scale
Each score corresponds to a defined set of observable clinical signs and a recommended action. Assess the peripheral IV cannula site at each care contact and document the score.
For audit and surveillance purposes, a VIP Score of 2 or above is classified as phlebitis. Score 1 is not counted as phlebitis but should trigger increased vigilance. Scores of 3, 4, and 5 indicate a level at which clinical practice standards should be carefully reviewed.
Clinical Rationale
Recording phlebitis as merely present or absent strips away the clinical information that drives decisions. The VIP Score's 0–5 structure is intentionally designed to preserve that nuance.
Each score from 0 to 5 carries a defined clinical response. There is no ambiguity — score 2 means remove the cannula; score 5 means initiate urgent treatment. A binary result cannot deliver this level of decision support.
Phlebitis rates calculated using a graded scale reveal the true severity distribution across a ward or organisation. Benchmarking against national standards requires granular data — a yes/no approach collapses this into a single, uninformative figure.
Score 1 is not phlebitis — but it is a warning. The scale allows clinicians to act before the threshold of established phlebitis is reached, potentially avoiding the need for cannula removal altogether through timely investigation of the cause.
A documented score provides objective, reproducible evidence of site status at each assessment. A numerical record is far more defensible in case of patient complaint or adverse event review than a narrative description.
The VIP Score has become a widely adopted tool for peripheral IV assessment across acute and community settings in many countries, featuring in local policies, national guidance and international education resources.
Successful implementation should produce consistently low scores. Rising scores are an objective signal that practice, device choice, or standards warrant review — something a binary system can never reveal.
Step-by-step guide
The VIP Score is quick to apply at the bedside. Follow these steps at each assessment to ensure consistent, reliable scoring.
Wash hands and don appropriate PPE before approaching the patient. Explain what you are doing and obtain consent. View the peripheral IV cannula site fully — remove any dressings that obscure the insertion point or surrounding skin.
Examine the skin around the cannula insertion point in good light. Look for: redness (erythema), swelling (oedema), such as induration or hardening, a visible red streak along the vein, or any purulence at the insertion point.
Gently palpate along the vein path proximal to the cannula tip. Ask the patient whether they have pain or tenderness at or near the site. Note whether palpation reveals a cord-like hardening (palpable venous cord) and whether pain is localised to the insertion point or extends along the vein.
Using the signs identified, select the score that most accurately matches the clinical picture. Start from score 0 and work upwards — assign the highest score supported by the signs present.
Act on the score immediately. Scores 0–1: document and continue monitoring. Score 2 and above: remove the peripheral IV cannula, document the score, and arrange re-siting if ongoing IV access is required. Scores 3–5: consider treatment for established phlebitis or thrombophlebitis and escalate to a senior clinician.
Record the numerical VIP score — not a description — in the patient's documentation at every assessment, with date, time, and clinician name. If the cannula is removed, note the score at removal, cannula site, and action taken.
Assessment frequency should match clinical need. The following is a general guide based on current evidence and best practice.
| Setting / circumstance | Minimum frequency |
|---|---|
| All patients with a peripheral IV cannula in situ | At each care contact / shift minimum |
| Continuous IV infusions running | Before, during, and after the infusion |
| Vesicant or irritant drugs (e.g. amiodarone, vancomycin, potassium) | Every 1–2 hours during infusion |
| Paediatric patients | Every hour, or per local policy |
| VIP Score 1 on previous assessment | Increase to hourly or as clinically indicated |
The VIP Score was originally developed by Jackson (1998) and has been widely adopted in clinical guidelines and national standards across the UK and beyond. Its 0–5 structure improves consistency of assessment, supports surveillance data collection, and reduces preventable phlebitis rates.
Frequently asked questions
Answers to the questions most frequently raised by clinicians, educators, and ward teams implementing the VIP Score in practice.
VIP stands for Visual Infusion Phlebitis. The name reflects how the score is applied: through visual inspection and clinical assessment of the peripheral IV cannula site, in the context of intravenous infusion therapy.
A VIP Score of 2 or above indicates phlebitis and the peripheral IV cannula should be removed. Score 2 is the validated intervention threshold. At score 1, the cannula may remain in situ subject to clinical review, but increased vigilance and investigation of the cause is required.
No. For surveillance and audit purposes, a score of 1 is not counted as phlebitis. However, score 1 should never be dismissed — it is a clinically meaningful signal to increase assessment frequency and investigate potential causes before phlebitis becomes established.
All three represent established, progressive phlebitis requiring prompt action:
At every care contact and at least every shift. When a continuous infusion is running, assess before, during, and after. For irritant or vesicant drugs, assess every 1–2 hours during infusion. If a previous assessment returned score 1, increase frequency accordingly.
Always document the numerical VIP Score. A number is unambiguous, reproducible, and supports audit data collection. Narrative descriptions are subjective and cannot be compared across clinicians, shifts, or time points.
Phlebitis surveillance counts episodes where the VIP Score reached 2 or above as reportable phlebitis events, expressed as episodes per 1,000 IV catheter days. Scores of 3–5 are particularly important for quality review. Consistently low scores following a robust assessment programme indicate IV therapy standards are being met.
IVTEAM provides downloadable and printable resources including a VIP Score reference poster and assessment forms — designed for display in clinical areas, patient documentation folders, and local education programmes. Visit the IVTEAM resources page to access the full library.